Login / Signup

Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor.

Miyako NaganumaNobumichi OhokaGenichiro TsujiTakao InoueMikihiko NaitoYosuke Demizu
Published in: Bioconjugate chemistry (2023)
Proteolysis-targeting chimeras (PROTACs) have attracted attention as a chemical method of protein knockdown via the ubiquitin-proteasome system. Some oligonucleotide-based PROTACs have recently been developed for disease-related proteins that do not have optimal small-molecule ligands such as transcription factors. We have previously developed the PROTAC LCL-ER(dec) , which uses a decoy oligonucleotide as a target ligand for estrogen receptor α (ERα) as a model transcription factor. However, LCL-ER(dec) has a low intracellular stability because it comprises natural double-stranded DNA sequences. In the present study, we developed PROTACs containing chemically modified decoys to address this issue. Specifically, we introduced phosphorothioate modifications and hairpin structures into LCL-ER(dec) . Among the newly designed PROTACs, LCL-ER(dec)-H46 , with a T4 loop structure at the end of the decoy, showed long-term ERα degradation activity while acquiring enzyme tolerance. These findings suggest that the introduction of hairpin structures is a useful modification of oligonucleotides in decoy oligonucleotide-based PROTACs.
Keyphrases
  • estrogen receptor
  • transcription factor
  • small molecule
  • high resolution
  • endoplasmic reticulum
  • protein protein
  • working memory
  • binding protein
  • cancer therapy
  • nucleic acid
  • drug delivery
  • mass spectrometry